Teladoc Health Reports Q2 Results with Strong Integrated Care Performance and Revised Revenue Outlook
Teladoc Health (NYSE:TDOC) reported second-quarter results within its guidance range, driven by strong performance in the Integrated Care segment. Consolidated revenue reached $607 million for the quarter, while adjusted EBITDA was $66 million with a margin of 10.8%. The company ended Q2 with $774 million in cash and reported free cash flow of $36 million. Integrated Care revenue rose by 0.7% year-over-year to $394 million, landing at the upper end of guidance. Adjusted EBITDA for this segment increased by 13.6%, reaching a margin of 16.5%. International growth and chronic-care enrollment were key contributors. However, BetterHelp's revenue declined both year-over-year (down 11.6%) and sequentially (2.6%), primarily due to lower cash-pay revenue. This led Teladoc to revise its full-year revenue outlook downward.
Tickers: $TDOC